1. Home
  2. LASE vs NSRX Comparison

LASE vs NSRX Comparison

Compare LASE & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Laser Photonics Corporation

LASE

Laser Photonics Corporation

HOLD

Current Price

$2.73

Market Cap

62.7M

Sector

Industrials

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$6.80

Market Cap

63.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LASE
NSRX
Founded
2019
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.7M
63.4M
IPO Year
2022
2025

Fundamental Metrics

Financial Performance
Metric
LASE
NSRX
Price
$2.73
$6.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$22.00
AVG Volume (30 Days)
268.4K
2.8K
Earning Date
04-02-2026
12-26-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,938,027.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
89.34
N/A
52 Week Low
$1.71
$5.90
52 Week High
$7.31
$9.99

Technical Indicators

Market Signals
Indicator
LASE
NSRX
Relative Strength Index (RSI) 39.98 N/A
Support Level $2.70 N/A
Resistance Level $3.06 N/A
Average True Range (ATR) 0.22 0.00
MACD 0.01 0.00
Stochastic Oscillator 4.92 0.00

Price Performance

Historical Comparison
LASE
NSRX

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: